Filters
| Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
|---|---|---|---|
Institute for Human Genetics University Medical Center Freiburg Germany | 1 | 1 |
|
OnkoRisk Hereditary Oncology Plus Panel BioReference Health United States | 97 | 77 |
|
OnkoRisk Hereditary Oncology Guideline Panel BioReference Health United States | 71 | 54 |
|
Hereditary Cancer Screening - Nervous System & Endocrine Cancer Panel (44 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 52 | 44 |
|
Hereditary Cancer Screening - Full Hereditary Cancer Panel (99 Genes) Genesys Diagnostics Genesys Diagnostics, Inc. United States | 109 | 99 |
|
SDHAF2 Gene Pheochromocytoma type 5 NGS Genetic DNA Test DNA Labs India India | 1 | 1 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 19 |
|
Hereditary Endocrine Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 24 |
|
Mayo Clinic Laboratories Mayo Clinic United States | 1 | 11 |
|
Hereditary Expanded Cancer Panel Mayo Clinic Laboratories Mayo Clinic United States | 1 | 86 |
|
Tempus Labs, Inc. United States | 2 | 647 |
|
Genomic Unity® Nuclear Encoded Mitochondrial Gene Analysis Variantyx, Inc. United States | 1 | 335 |
|
OncoAlly™ Comprehensive Hereditary Cancer Analysis Variantyx, Inc. United States | 1 | 88 |
|
Molecular Vision Laboratory United States | 1358 | 1028 |
|
Centogene AG - the Rare Disease Company Germany | 114 | 68 |
|
Centogene AG - the Rare Disease Company Germany | 156 | 107 |
|
SDHAF2 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 1 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 1886 | 1858 |
|
Centogene AG - the Rare Disease Company Germany | 406 | 414 |
|
Invitae Multi-Cancer + RNA Panel Invitae United States | 143 | 63 |
|
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.